InvestorsHub Logo
Followers 5
Posts 213
Boards Moderated 0
Alias Born 08/19/2013

Re: Darwinian post# 1119

Thursday, 07/24/2014 12:05:30 PM

Thursday, July 24, 2014 12:05:30 PM

Post# of 3839
Quote:

"Worse yet, diagnostics outside of a biopsy are lacking"

Guess the author never heard of FibroTest, ELF and FibroScan.

The Sampling Error with a biopsy makes it no better than the above 3 methods, even less accurate. You would need to turn the liver into Swiss cheese to have a accurate representation of the condition of the liver.
This is the problem with Phase1, the market doesn't realize Cohort1 results showed with a reasonable % that there was some reversal. Cohort2 adds the FibroScan, will the Market catch on this time?

http://www.biomedcentral.com/1471-230X/10/103
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News